Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090532
Status:
TERMINATED
Last Update Posted:
2011-05-27
First Post:
2004-08-26
Brief Title:
A Study Of The Safety And Efficacy Of AG-013958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 12 Randomized Masked Single and Multiple-Dose Sequential Dose-Escalation Study of the Safety an Efficacy of AG-013958 in Subjects With Subfoveal Choroidal Neovascularization Associated With Age-related Macular Degeneration
Status:
TERMINATED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study was terminated due to a lack of efficacy
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
AG-013958 is being studied to treat patients with Age-Related Macular Degeneration A total of 144 subjects may be enrolled in the trial Subjects will be male or female at least 55 years of age with wet age-related macular degeneration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None